Related Experiment Videos
The Fas counterattack: a molecular mechanism of tumor immune privilege
J O'Connell1, M W Bennett, G C O'Sullivan
1Department of Medicine, National University of Ireland, Cork, Ireland.
Molecular Medicine (Cambridge, Mass.)
|May 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Modulation, microbiota and inflammation in the adult CF gut: A prospective study.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022
Metagenomic assembled plasmids of the human microbiome vary across disease cohorts.
Scientific reports·2022
Mapping the colorectal tumor microbiota.
Gut microbes·2021
The fecal mycobiome in patients with Irritable Bowel Syndrome.
Scientific reports·2021
P1D6 inhibits FnBP-induced extracellular proteome remodeling: proteomic evidence for a novel intervention strategy in atopic dermatitis.
Molecular medicine (Cambridge, Mass.)·2026
WHAMM deficiency alters splenic B-cell populations, BCR signaling, and actin remodeling.
Molecular medicine (Cambridge, Mass.)·2026
Drugs inducing interstitial lung disease: in silico analysis of their structures and targets.
Molecular medicine (Cambridge, Mass.)·2026
O-GlcNAcylation: the metabolic-immune translator in tumor evolution and treatment.
Molecular medicine (Cambridge, Mass.)·2026
Thyroid hormones and hearing loss.
Molecular medicine (Cambridge, Mass.)·2026
Serum meprin α levels for the detection of systemic inflammatory response syndrome.
Molecular medicine (Cambridge, Mass.)·2026
Spatial Constraints Limit Natural Killer Cell Access to Germinal Centre HIV Reservoirs in Lymph Nodes.
The Journal of infectious diseases·2026
Trained Immunity in Childhood Vaccination.
Acta paediatrica (Oslo, Norway : 1992)·2026
Balancing inflammation under stress: glucocorticoid regulation of innate immune pathways.
Bioscience reports·2026
Alimatravir Oral Once Monthly in Adults With Low Likelihood of HIV Exposure: A Randomized, Double-Blind, Placebo-Controlled Study.
The Journal of infectious diseases·2026